Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA2929 Thalidomide-NH-CH2-COOHSummary: Thalidomide-NH-CH2-COOH is a Thalidomide-based, ligand that recruits CRBN proteins. -
BA2930 CearoinSummary: Enhances autophagy and induces apoptosis by promoting the production and activation of... -
BA2931 CipepofolSummary: Cipepofol (Ciprofol) is a novel 2,6-disubstituted phenol derivative that is a direct agonist and orthosteric modulator of receptors. -
BA2932 alpha-BisabololSummary: alpha-Bisabolol is an orally active sesquiterpene alcohol that induces cell cycle arrest, mitochondrial apoptosis and inhibits signaling pathways. -
BA2934 ThienopyridoneSummary: Thienopyridone is a potent and selective inhibitor of hepatic regenerative phosphatase phosphatase. -
BA2935 STM3006Summary: STM3006 is a potent, selective, orally active inhibitor. -
BA2937 ZINC69391Summary: ZINC69391 is a specific inhibitor that interferes with the Rac1-GEF interaction by masking the Trp56 residue on the Rac1 surface. -
BA2938 STAT3-IN-11Summary: STAT3-IN-11(7a) is a selective inhibitor of site-specific phosphorylation. -
BA2939 NeriifolinSummary: Neriifolin is a cardiac glycoside that penetrates the central nervous system and is a depressant. -
BA2940 TP-472Summary: TP-472 is a BRD9 and BRD inhibitor.

